<DOC>
	<DOCNO>NCT02991950</DOCNO>
	<brief_summary>Prospective randomize study patient infertility candidate Assisted ReproductiveTechniques ( ART ) , screen inclusion exclusion criterion , submit ART cycle without low molecular weight heparin ( LMWH ) administration . Aims study evaluate , primarily , pregnancy rate/embryo transfer , secondarily take home babies/embryo transfer , implantation rate , role thrombophilic factor</brief_summary>
	<brief_title>Weight Adjusted Low Molecular Weight Heparin Recurrent Implantation Failure : Randomized Open Labeled Trial</brief_title>
	<detailed_description>This interventional , stratify , randomize , open blind study . It conduct outpatient select basis inclusion exclusion criterion . Patients randomise accord computer generate list randomization receive LMWH prophylactic daily dosage ( 100 IU/kg ) . For correct selection analysis parameter check randomization ( see randomization check list end ) . The woman LMWH arm treat starting day begin stimulation phase cycle ART result procedure confirm term pregnancy yes , pregnancy confirm delivery end pregnancy . Women control arm administer routine hormonal support without LMWH . Data collect smoking habit , BMI , number retrieve oocyte , transfer embryos implantation rate , ART outcome parameter use randomization basis inclusion exclusion criterion . During study blood collect analysis randomization , moment wich patient assign one two arm , transfer day check betaHCG case pregnancy woman check 12 , 24 , 36 week test functional parameter coagulation ( protein C , protein S , AT , ddimer , fibrinogen , PT , aPTT , FVII , FVIII , FIX , vonWillebrand factor antigen ) , blood cell count lipid ( cholesterol triglyceride ) . The sample , identify sequential identification number , collect , process storage -20/-80°C promoter center destroy analysis . Study treatment Women LMWH arm administer prophylactic weight adjust dose LMWH , start day begin stimulation phase cycle result procedure confirm term pregnancy yes case pregnancy delivery end pregnancy . Women LMWH arm test blood cell count twice first 10 day therapy . Initial dose schedule Parnaparin administer dose 100 IU/kg/day day begin stimulation phase cycle result procedure confirm term pregnancy yes case pregnancy delivery end pregnancy . None patient receive concomitant acetylsalicylic acid ( ASA ) steroids therapy Treatment duration Women LMWH arm administer prophylactic weight adjust dose parnaparin , start day begin stimulation phase cycle result procedure confirm term pregnancy yes case pregnancy delivery end pregnancy . Whatever disease status , treatment always discontinue case patient refusal excessive toxicity preclude therapy , accord responsible physicianother complication , accord responsible physician</detailed_description>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Women ≥18 year ≤40 year , candidated fresh IVF/ICSI cycle routine ovulation induction protocol vvCouples candidated frozen IVF/ICSI cycle routine ovulation induction protocol Testicular frozen sperm ( TESE procedure allow ) Presence hormonal disorder compensate specific therapy history immunological disease ( autoimmune thyroiditis , connectivitis , RA , SLE , etc ) Presence antiphospholipides autoantibody severe thrombophilia ( AT , PS , PC deficiency homozygous FV Leiden FIIG20210A , double eterozygous FV Leiden FIIG20210A ) Presence abnormal platelet count congenital acquire coagulopathy ASA steroid therapy administration</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>